Join The Community

Summary

The product Turinabol, manufactured by Imperium Pharma, underwent independent testing to verify its concentration and quality. The sample, identified by batch number 02/2027, was submitted by Anonymous and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis determined that the Turinabol concentration was 10.95 mg.

The testing process began on 16 December 2024, with the sample received on 8 January 2025, and analysis completed on 13 January 2025. While the results confirm the presence of Turinabol, further scrutiny is necessary to ensure consistency across different batches. Independent third-party testing remains essential for comprehensive validation. This report is published as an educational resource to promote harm reduction and informed decision-making.

Detailed Report

Product Overview

Sample Acquisition and Testing

Testing Results

Verification Details

Verification URL: https://janoshik.com/tests/55658_CARL5THW5UIG

Evaluation of Manufacturer-Submitted Testing

This analysis confirms that the tested product contains Turinabol at a measured concentration of 10.95 mg. Since this sample was submitted anonymously, careful evaluation is required to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, independent verification across multiple samples is recommended to establish broader reliability.

Conclusion

The analysis verifies the presence of Turinabol at a concentration of 10.95 mg. While this result indicates the product’s potency, additional testing would be beneficial to ensure consistent dosing across different production batches. This report serves as an educational resource for harm reduction and informed decision-making in pharmaceutical use.

Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it still provides useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.